Form 4: Amicus Therapeutics Executive Samantha Prout Reports Stock Disposal
SEC Form 4 Filing
Samantha Prout, Chief Accounting Officer of Amicus Therapeutics, disposed of 7,027 shares of common stock on April 15, 2024.
Summary
- On April 15, 2024, Samantha Prout, the Chief Accounting Officer of Amicus Therapeutics, disposed of 7,027 shares of common stock.
- The transaction was executed at a price of $10.66 per share.
- Following the transaction, Prout directly owns 73,926 shares of Amicus Therapeutics.
- The transaction was reported on April 16, 2024.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of an insider transaction. The sentiment is neither positive nor negative without additional context.
Industry Context
Form 4 filings are standard disclosures required by the SEC for company insiders, providing transparency into their trading activities. These filings are closely watched by investors for signals about management's view of the company's prospects.
Stakeholder Impact
- Shareholders may interpret insider selling as a lack of confidence in the company's future performance, although this single transaction may not be significant on its own.
Key Dates
| Date | Description |
|---|---|
| 04/15/2024 | Date of stock disposal transaction |
| 04/16/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.